The January 1999 issue of The Physician’s Therapeutics & Drug Alert contained two errors. In the Pharmacology Update article (Elliott WT. PTDA 1999;6:41-42), it was reported that celecoxib received FDA approval for post-dental surgical pain. Celecoxib did not receive FDA approval for post-dental surgical pain. In the same Pharmacology Update article, it was reported that gabapentin has been shown to be effective in treating postherapeutic neuralgia. Gabapentin has been shown to be effective in the treatment of postherpetic neuralgia. We regret any confusion these errors may have caused.